Glatiramer Acetate Follow-up in Participants From the Original Study for Safety and Effectiveness
Study Title
- Glatiramer Acetate (Copaxoneֲ®) Study to Follow Participants From the First Original Study for Safety and Effectiveness
Teva Identifier
- GA-9004 | 01-9004
ClinicalTrials.gov Identifier
- NCT00203021
Study Status
- Completed
Trial Condition(s)
- Relapsing-Remitting Multiple Sclerosis
Interventions
- Drug: Glatiramer acetate
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- March 26, 1994 - February 28, 2018
Phase
- Phase 4
Study Type
Interventional
